Clinical Trial Update: Dyskinesia in Parkinson's Disease (Study P04501) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on dyskinesia in Parkinson's disease (Study P04501) completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson Disease, Movement Disorders | Phase 2 | Status: COMPLETED | Results posted: 2017-02-08